Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography–tandem mass spectrometry

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

Joachim Stangier, Karin Rathgen, Hildegard Stähle et al. · British Journal of Clinical Pharmacology · 2007 · 884 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross‐sectional pharmacodynamic study based on peak and trough plasma levels

E. M. Hawes, Allison M. Deal, D. Funk‐Adcock et al. · Journal of Thrombosis and Haemostasis · 2013 · 231 citations

Medicine, Pharmacokinetics, Pharmacology +17

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty

Neil Roskell, Jonathan Plumb, Joseph A. Caprini et al. · Thrombosis and Haemostasis · 2008 · 184 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Anne Tamigniau, Bernard Châtelain, C Chatelain et al. · Thrombosis and Haemostasis · 2013 · 150 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16